National Institute of Allergy and Infectious Diseases
Link to NIAID Home Page Link to NIAID Home Page Link to NIH Home Page
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

About NIAID
 Overview
 Organization
  Organizational Charts
  Office of the Director
  DAIDS
  DAIT
  DCR
  DEA
  DIR
  DMID
  VRC
 Director's Page
 Working at NIAID
 Finding People
 Visitor Information


Division of Acquired Immunodeficiency Syndrome (DAIDS)

Network Coordination

The Office of HIV/AIDS Network Coordination (HANC)

The Office of HIV/AIDS Network Coordination (HANC) works with NIAID and the HIV/AIDS Clinical Trials Networks to facilitate collaboration and coordination on priority areas of research and operations, increase communication, and streamline processes to improve research efficiency. In addition to coordinating the efforts of the leadership principal investigators, inter-network coordination encompasses, among other areas, statistical and data management, laboratory, training, evaluation, clinical trials logistics, and community participation and education. Information about coordinated network activities can be found at www.hanc.info.

The Strategic Working Group (SWG)

The Strategic Working Group (SWG) provides expert advice on the scientific priorities of the NIAID-funded HIV/AIDS Clinical Trials Networks. Specifically, the SWG serves as a forum for discussion, resolution, and proactive planning of critical issues; provides guidance on scientific priorities for future high resource trials, provides input about budget allocation for future funding of the networks and sites, and facilitates communication among all stakeholders relevant to the NIAID-sponsored HIV/AIDS Clinical Trials Networks. The SWG meets two to three times a year, and members include the network principal investigators, NIAID-appointed external advisors, representatives from the Community Partners, and the director of DAIDS.

The Community Partners (CP)

The Community Partners (CP) is a group established to promote effective representation of and timely communication among the many communities, in the U.S. and internationally, that work with and participate in the NIAID-funded HIV/AIDS Clinical Trials Networks. The Community Partners is comprised of representatives from each of the NIAID networks community groups, including the AIDS Clinical Trials Group (ACTG), the HIV Vaccine Trials Network (HVTN), the HIV Prevention Trials Network (HPTN), the International Maternal Pediatric Adolescent AIDS Clinical Trials group (IMPAACT), the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), and the Microbicide Trials Network (MTN); staff from each of these networks and DAIDS will also participate as non-voting participants. Responsibilities of the Community Partners include enhancing intra- and inter-network community input at all levels, identifying and developing programs to meet the training and support requirements of local Community Advisory Boards, increasing the representation and participation of community representatives from resource-limited settings, and identifying and addressing challenges and concerns to participation in clinical trials.

back to top


News Releases 

Clinical Trials Units Selected for Newly Restructured HIV/AIDS Research Networks
March 12, 2007


Highlights

Dr. Carl Dieffenbach Appointed Director of the NIAID Division of AIDS
Feb. 1, 2008

News Releases

Statement of Dr. Anthony S. Fauci on the Death of Martin Delaney
Jan. 23, 2009

NIAID Honors AIDS Activist Martin Delaney
Jan. 19, 2009

NIAID Media Availability: Well-Armed Immune Cells Help Long-Term Non-Progressors Contain HIV
Dec. 4, 2008

NIAID Media Availability: World AIDS Day Offers a Reflection on the Past, Hopeful Look to the Future
Nov. 28, 2008

Landmark Study Defines Benefits of Early HIV Testing and Treatment for Infected Infants
Nov. 19, 2008

Special Announcements

Status of NIAID Adenovirus-based Vaccine Studies

Considerations for HIV Vaccine Clinical Trials in Adolescents

Guidance regarding HIV anti-retroviral treatment in developing countries

 
E-mail Icon E-mail this page
Print Icon Print this page


News Releases 

Clinical Trials Units Selected for Newly Restructured HIV/AIDS Research Networks
March 12, 2007


Highlights

Dr. Carl Dieffenbach Appointed Director of the NIAID Division of AIDS
Feb. 1, 2008

News Releases

Statement of Dr. Anthony S. Fauci on the Death of Martin Delaney
Jan. 23, 2009

NIAID Honors AIDS Activist Martin Delaney
Jan. 19, 2009

NIAID Media Availability: Well-Armed Immune Cells Help Long-Term Non-Progressors Contain HIV
Dec. 4, 2008

NIAID Media Availability: World AIDS Day Offers a Reflection on the Past, Hopeful Look to the Future
Nov. 28, 2008

Landmark Study Defines Benefits of Early HIV Testing and Treatment for Infected Infants
Nov. 19, 2008

Special Announcements

Status of NIAID Adenovirus-based Vaccine Studies

Considerations for HIV Vaccine Clinical Trials in Adolescents

Guidance regarding HIV anti-retroviral treatment in developing countries